Concepedia

Ian F. Tannock

IF

273

Publications

40.7K

Citations

89

H-Index

1967

Active since

Affiliations

Princess Margaret Cancer Centre(Current)

University of Toronto

Ontario Institute for Cancer Research

University Health Network

Johns Hopkins University

Ian F. Tannock is an author at Princess Margaret Cancer Centre specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1967–2025

273

Publications

273

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Howard I. Scher, Susan Halabi, Ian F. Tannock et al. · Journal of Clinical Oncology · 2008 · 2.2K citations · Full text

Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial

Camilla Zimmermann, Nadia Swami, Monika K. Krzyzanowska et al. · The Lancet · 2014 · 1.7K citations

, , +9

Acid pH in tumors and its potential for therapeutic exploitation.

Ian F. Tannock, Daniela Rotin · PubMed · 1989 · 1.6K citations

, , +19

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

Dominik Berthold, Gregory R. Pond, Freidele Soban et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

Rows per page

1–5 of 273